Due to its role in nucleotide excision repair (NER), it is not surprising that decreased DDB2 expression has been reported in various cancerous tissues, for instance, in prostate [91], skin [92], head and neck [93], and ovarian cancer [96]. This evidence concerns the gene DDB2 and ovarian carcinoma.